HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tingting Oian Selected Research

sauristolactam

3/2011The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tingting Oian Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
03/2011
1Neoplasms (Cancer)
03/2011

Drug/Important Bio-Agent (IBA)

1sauristolactamIBA
03/2011
1KO 202125IBA
03/2011
1Gefitinib (Iressa)FDA Link
03/2011
1Estrogen ReceptorsIBA
03/2011
1ErbB Receptors (EGF Receptor)IBA
03/2011

Therapy/Procedure

1Therapeutics
03/2011